Naloxonazine
From Wikipedia, the free encyclopedia
Names | |
---|---|
Other names
NIH 10894; NSC 612113, Bis-[5-α-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)-morphinan-6-ylidene] hydrazine dihydrochloride
|
|
Identifiers | |
82824-01-9 | |
ChEMBL | ChEMBL1618376 |
ChemSpider | 7850858 |
1677 | |
Jmol 3D model | Interactive image |
PubChem | 9576413 |
|
|
|
|
Properties | |
C38H42N4O6 | |
Molar mass | 650.78 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Naloxonazine is a potent, irreversible μ-opioid receptor antagonist.[1] Naloxonazine forms spontaneously in acidic solutions of naloxazone, and may be responsible for much or all of the irreversible μ opioid receptor binding displayed by the latter.[2]
See also[edit]
- Oxymorphone-3-methoxynaltrexonazine (OM-3-MNZ) a similarly structured opioid also having two complete and mirrored morphinan carbon skeletons but which is a full agonist instead.[citation needed][3]
References[edit]
- ^ Naloxonazine dihydrochloride
- ^ Hahn, E. F.; Pasternak, G. W. (September 1982). "Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites". Life Sciences. 31 (12-13): 1385–1388. doi:10.1016/0024-3205(82)90387-3. PMID 6292633. Retrieved 2011-10-18.
- ^ Image of OM-3-MNZ
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |